SCHEMBL3974207

SCHEMBL3974207

COc1ccc(C(=O)OC(=O)c2occ(-c3ccccc3)c2-c2ccccc2)c(C(=O)NN)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.37
CTSD P07339 1/20 0.37
POLB P06746 2/20 0.36
TP53 P04637 1/20 0.36
LMNA P02545 3/20 0.35
ALDH1A1 P00352 3/20 0.35
HTT P42858 2/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HDAC8 Q9BY41 1/20 0.34
SLC9A1 P19634 1/20 0.34
FABP4 P15090 2/20 0.34
FABP3 P05413 1/20 0.34
FABP5 Q01469 1/20 0.34
MEN1 O00255 1/20 0.34
MAPK1 P28482 1/20 0.34
PPARG P37231 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3974632 0.92 CTSD (0.38) CTSDPOLBTP53LMNAALDH1A1
SCHEMBL3978639 0.90 HTT (0.37) CTSDPOLBTP53LMNAALDH1A1
SCHEMBL3978027 0.90 CTSD (0.37) ACLYCTSDPOLBTP53LMNA
SCHEMBL3977002 0.90 POLB (0.37) CTSDPOLBTP53LMNAALDH1A1
SCHEMBL3982340 0.90 CTSD (0.36) ACLYCTSDPOLBTP53LMNA
SCHEMBL3982135 0.87 MEN1 (0.34) LMNAALDH1A1KDM4EMAPTKMT2A
SCHEMBL3978783 0.87 S1PR1 (0.35) ACLYCTSDPOLBTP53LMNA
SCHEMBL3980558 0.87 POLB (0.38) CTSDPOLBTP53LMNAALDH1A1
SCHEMBL3979544 0.87 HPGD (0.41) CTSDLMNAALDH1A1HTTKDM4E
SCHEMBL3982901 0.86 TP53 (0.33) ACLYCTSDPOLBTP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 ACLY 313/4885CTSD 2014/4885POLB 4676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.